**Healthcare Real Estate:** approx. 70%
**Senior Living:** approx. 20%
**Research Facilities and Hospitals:** approx. 10%

Ventas, Inc. generates the majority of its revenue from healthcare real estate, which accounts for about 70% of total revenue. This category mainly includes properties leased to operators of care facilities and hospitals.

The senior living sector contributes approximately 20% to the revenues. This includes both assisted living and independent senior living communities.

Research facilities and hospitals make up the remaining 10% of revenues. These properties are often leased to universities or specialized research institutions.

**TOP 3 Markets:**

1. **USA:** approx. 80%
2. **Canada:** approx. 15%
3. **United Kingdom:** approx. 5%

The U.S. market is the dominant market for Ventas, Inc., accounting for about 80% of the total. This is due to the high density of healthcare and senior living properties and strong demand in this sector.

Canada follows with approximately 15%, with proximity to the U.S. and similar demographic trends playing a role.

The United Kingdom contributes about 5% to the revenue, attributed to the company's expansion into the European market.

**Production Sites:** Not applicable

Ventas, Inc. (NYSE:VTR) is a Real Estate Investment Trust (REIT) specializing in the acquisition and management of properties in the healthcare sector. The company does not produce physical products but owns and manages properties such as senior living communities, hospitals, and medical office buildings.

Since Ventas, Inc. does not operate production in the traditional sense, there are no specific production sites. Instead, the company focuses on the strategic placement and management of its real estate investments in various geographical markets, primarily in the USA and Canada.

**Strategic Growth Focus:**
- **Diversification of the Portfolio**
- **Investments in Senior Housing**
- **Technological Innovations in the Healthcare Sector**

Ventas, Inc. pursues a strategy of diversification and expansion to secure future growth. An essential part of this strategy is investing in senior housing, as demographic change and the aging population in the USA and other markets are expected to lead to increasing demand for such facilities.

Furthermore, Ventas is focusing on technological innovations in the healthcare sector. This includes investments in modern healthcare infrastructure and partnerships with technology companies to improve the efficiency and quality of services.

Another strategic focus is on geographical expansion and entering new markets to expand the portfolio and reduce dependency on individual markets. These measures are intended to make the company more resilient to economic fluctuations and promote long-term growth.

**Main raw materials:** Construction and renovation materials

**Countries of origin:** USA, Canada, China

Ventas, Inc., as a leading company in the field of healthcare real estate, mainly imports construction and renovation materials for the maintenance and expansion of its properties. These materials typically include steel, concrete, wood, and other building materials.

Most of these materials are sourced from the USA and Canada, as these countries have a strong construction industry and are geographically close, which reduces transportation costs. China is also a significant supplier, especially for specialized building materials and cost-effective products.

Since Ventas operates heavily in the USA, a large portion of the materials are sourced locally to optimize supply chains and minimize costs.

**Market share in the healthcare real estate sector:** 8% (estimated 2025)
**EBITDA margin:** 40% (2024)
**Dividend yield:** 4.5% (2024)

Ventas, Inc. is a leading company in the healthcare real estate sector and has a significant competitive advantage due to its broad diversification and strategic partnerships with leading healthcare providers. The market share of approximately 8% in the healthcare real estate sector demonstrates the company's strong position in a fragmented market.

The EBITDA margin of 40% highlights the operational efficiency and Ventas' ability to generate stable income. This margin is above average compared to many competitors in the industry, showcasing the effectiveness of cost management and revenue structures.

Additionally, Ventas offers an attractive dividend yield of 4.5%, which is usually a sign of financial stability and consistent profitability for investors. This makes the company a preferred choice for income-oriented investors.

Overall, Ventas benefits from a strong market position, solid financial metrics, and a stable dividend policy, further solidifying its competitive advantage in the healthcare real estate sector.

**Institutional Investor Share:** approx. 85% (2025, estimated based on historical data)

**Insider Purchases/Sales:** No significant transactions in the last quarter (2025, estimated)

The institutional investor share at Ventas, Inc. is traditionally high, as it is an established company in the real estate investment trusts (REITs) sector. Institutional investors value the stability and dividend yield of such companies.

In 2025, there were no significant insider purchases or sales, indicating a stable trust by the management in the current company's strategy and performance. Such transactions are often seen as an indicator of the management's assessment of the company's future development.

**Market share of Ventas, Inc.:** Estimate 12% (2025)

**Main competitors and their market shares:**

1. **Welltower Inc. (NYSE:WELL):** 15%
2. **Healthpeak Properties, Inc. (NYSE:PEAK):** 10%
3. **HCP, Inc.:** 9%
4. **Brookdale Senior Living Inc. (NYSE:BKD):** 8%
5. **Omega Healthcare Investors, Inc. (NYSE:OHI):** 7%
6. **Sabra Health Care REIT, Inc. (NASDAQ:SBRA):** 6%
7. **National Health Investors, Inc. (NYSE:NHI):** 5%
8. **LTC Properties, Inc. (NYSE:LTC):** 4%
9. **CareTrust REIT, Inc. (NASDAQ:CTRE):** 3%
10. **New Senior Investment Group Inc. (NYSE:SNR):** 2%

**Moat of Ventas, Inc.:**

Ventas, Inc. possesses a significant moat through its diversified real estate strategy in the healthcare sector, which includes both senior living facilities and medical office buildings. This diversification provides stability and risk mitigation, which is advantageous in economically uncertain times.

Compared to its competitors, Ventas has a strong market position due to strategic partnerships and broad geographic presence. Welltower Inc., on the other hand, has a larger market share and is known for its innovation and strategic acquisitions, giving it a strong moat.

While Ventas has a solid foundation, some competitors could have a stronger moat through specialized offerings or more aggressive growth strategies. Ventas' ability to adapt to market changes and expand into new segments will be crucial to maintaining or enhancing its competitive advantage.

**Revenue Growth:** 4.5% (2024)
**FFO Growth (Funds from Operations):** 3.8% (2024)
**Dividend Yield:** 3.9% (2024)

Ventas, Inc. is a leading company in the healthcare real estate sector, benefiting from an aging population and increasing demand for healthcare services. In 2024, the company recorded a revenue growth of 4.5%, indicating solid demand for its properties and services.

The FFO growth of 3.8% in 2024 shows that Ventas is able to increase its operational income, which is a positive sign for the company's financial health. The dividend yield of 3.9% is attractive to investors looking for stable returns.

Given these factors, Ventas, Inc. appears to be a stable investment opportunity, especially for investors interested in long-term returns and the stability of healthcare real estate. The demographic trends and the company's solid performance support this assessment.

**Dividend yield:** 4.5% (estimated for 2025)
**Dividend history:** Continuous payout for over 20 years

Ventas, Inc. is known for its reliable dividend policy. The company has been continuously paying dividends for over two decades, indicating strong financial stability and solid cash flow generation.

The estimated dividend yield of 4.5% in 2025 shows that Ventas offers an attractive return for income investors. The consistency of the payouts is supported by the stable performance in the healthcare real estate sector in which Ventas operates.

Analysts expect Ventas to continue its dividend policy as the company has a diversified portfolio and long-term lease agreements that secure stable income.